High-dose vitamin D supplements do not improve heart recovery after a heart attack and may increase certain complications, according to the Target-D trial published in the European Heart Journal. The study of approximately 2,000 heart attack patients found that those receiving high-dose vitamin D had no better outcomes than those receiving placebo, challenging the common belief that vitamin D is universally beneficial for heart patients.

A major new study called Target-D found that taking high-dose vitamin D supplements after a heart attack didn’t improve heart health and may have caused problems. Researchers followed heart attack patients who received either high-dose vitamin D or a placebo to see if the vitamin would help their hearts heal better. According to Gram Research analysis, the results surprised many doctors: more vitamin D wasn’t better, and in some cases, it appeared to increase certain risks. This challenges the common belief that vitamin D is always beneficial for heart patients.

Key Statistics

The Target-D randomized controlled trial of approximately 2,000 heart attack patients found that high-dose vitamin D supplementation provided no improvement in heart function or major cardiac outcomes compared to placebo.

In the 2026 Target-D trial, high-dose vitamin D supplementation appeared to increase certain complications in heart attack patients, suggesting that more vitamin D is not necessarily better for cardiac recovery.

According to Gram Research analysis of the Target-D trial, even heart attack patients with low baseline vitamin D levels showed no benefit from high-dose supplementation, indicating that correcting deficiency with very high doses may not improve outcomes.

The Quick Take

  • What they studied: Whether giving heart attack patients high doses of vitamin D would help their hearts recover better than not giving it
  • Who participated: Approximately 2,000 people who had recently suffered a heart attack, randomly assigned to receive either high-dose vitamin D supplements or a placebo (fake pill)
  • Key finding: High-dose vitamin D supplementation did not improve heart function after a heart attack and may have increased certain complications compared to placebo
  • What it means for you: If you’ve had a heart attack, taking extra vitamin D supplements beyond normal levels probably won’t help your recovery and could potentially cause harm. Talk to your doctor before starting any vitamin D supplements, especially in high doses.

The Research Details

The Target-D trial was a randomized controlled trial, which is considered the gold standard in medical research. Researchers took about 2,000 heart attack patients and randomly divided them into two groups: one group received high-dose vitamin D supplements, while the other group received a placebo (a pill that looked identical but contained no active ingredient). Neither the patients nor the doctors knew who was getting the real vitamin D, which helps prevent bias. The patients were followed for several years, and researchers measured various heart health markers and complications.

This type of study design is powerful because the random assignment means the two groups should be very similar at the start, so any differences in outcomes are likely due to the vitamin D rather than other factors. The long follow-up period allowed researchers to see both short-term and long-term effects of the supplementation.

This research matters because many doctors and patients believed that vitamin D was universally beneficial for heart health, especially after a heart attack. Previous smaller studies suggested vitamin D might help, so this large, rigorous trial was needed to test whether high-dose supplementation actually works. The results challenge a common assumption and help doctors make better decisions about which supplements to recommend.

This study was published in the European Heart Journal, one of the world’s most respected medical journals, which means it underwent rigorous peer review. The randomized, controlled design is the strongest type of evidence available. The large sample size of approximately 2,000 participants makes the results more reliable than smaller studies. The fact that neither patients nor doctors knew who received the real vitamin D reduces bias. However, the study focused specifically on heart attack patients, so results may not apply to other populations.

What the Results Show

The main finding was that high-dose vitamin D supplementation did not improve heart function or reduce major heart problems in heart attack patients compared to placebo. This was surprising to many researchers who expected vitamin D to be protective. The vitamin D group did not show better recovery, fewer repeat heart attacks, or improved survival rates.

In fact, some concerning signals emerged. The high-dose vitamin D group appeared to have increased rates of certain complications, though researchers are still analyzing exactly which complications were affected and why. This suggests that more vitamin D isn’t automatically better and that very high doses might actually interfere with the body’s natural healing processes after a heart attack.

The results were consistent across different patient subgroups, meaning the lack of benefit wasn’t just limited to certain types of patients. Whether patients were older or younger, male or female, the high-dose vitamin D didn’t provide the expected heart protection.

Secondary analyses looked at whether vitamin D might help specific subgroups of patients, such as those with low vitamin D levels at the start of the study. Even in patients who were deficient in vitamin D, the high-dose supplementation didn’t improve outcomes. This suggests that simply correcting a vitamin D deficiency with very high doses may not be the right approach for heart attack recovery. Researchers also examined different measures of heart function and inflammation, but high-dose vitamin D didn’t improve these markers either.

Previous research had suggested vitamin D might be beneficial for heart health, leading many doctors to recommend supplements to heart patients. Some smaller studies showed associations between low vitamin D and worse heart outcomes. However, this large, well-designed trial shows that simply giving high-dose vitamin D doesn’t translate into better results. This is a common pattern in medicine: observational studies (which show that people with low vitamin D have worse outcomes) don’t always lead to benefits when you actually give people the supplement. The Target-D results align with other recent large trials that have questioned whether vitamin supplementation is as universally beneficial as once believed.

The study focused specifically on heart attack patients, so the results may not apply to people with other heart conditions or to the general population. The study used high doses of vitamin D, so it doesn’t tell us whether normal supplementation levels might be helpful. Some patients may not have taken their pills consistently, which could affect results. The study was conducted in certain geographic regions, so results might differ in areas with different baseline vitamin D levels or different populations. Additionally, the study couldn’t determine exactly why high-dose vitamin D appeared harmful, so more research is needed to understand the mechanisms.

The Bottom Line

If you’ve had a heart heart attack, do not start high-dose vitamin D supplements without talking to your cardiologist first. If you have low vitamin D levels, discuss with your doctor whether normal-dose supplementation (not high-dose) might be appropriate, but don’t assume it will improve your heart recovery. Focus on proven heart attack recovery strategies like cardiac rehabilitation, medications prescribed by your doctor, and lifestyle changes. Confidence level: High - this recommendation is based on a large, rigorous clinical trial.

Heart attack patients should definitely pay attention to this research, as it directly affects their recovery care. Cardiologists and heart specialists need to reconsider their vitamin D supplementation recommendations. People with low vitamin D levels who are worried about heart health should discuss this study with their doctors before starting high-dose supplements. People without heart disease should not assume this study applies to them, as the results are specific to heart attack recovery.

The Target-D trial followed patients for several years, so the lack of benefit was observed over an extended period. If you’re considering vitamin D supplementation, don’t expect to see heart health improvements within weeks or months. Any changes in heart function would likely take months to years to develop. However, the concerning signals about potential harm appeared within the study timeframe, suggesting that if high-dose vitamin D is going to cause problems, they may develop relatively quickly.

Frequently Asked Questions

Should I take vitamin D supplements if I’ve had a heart attack?

The Target-D trial found high-dose vitamin D didn’t help heart attack patients and may have caused harm. Talk to your cardiologist before starting any vitamin D supplements. Focus on proven recovery strategies like cardiac rehabilitation and prescribed medications instead.

Is vitamin D good for heart health?

While some research suggested vitamin D might help hearts, the large Target-D trial found high-dose supplements didn’t improve outcomes in heart attack patients. Normal vitamin D levels are important for overall health, but supplementing beyond that may not provide heart benefits.

What should heart attack patients do instead of taking vitamin D?

Focus on proven recovery methods: take prescribed heart medications, attend cardiac rehabilitation programs, exercise as recommended, eat a heart-healthy diet, manage stress, and quit smoking. These approaches have strong evidence for improving outcomes after heart attacks.

Can too much vitamin D be harmful?

The Target-D trial suggests high-dose vitamin D supplementation may increase certain complications in heart attack patients. Very high doses can potentially cause problems, which is why it’s important to discuss supplementation with your doctor rather than self-treating.

What if I have low vitamin D levels after a heart attack?

Even patients with low vitamin D showed no benefit from high-dose supplements in the Target-D trial. Discuss with your cardiologist whether normal-dose supplementation might be appropriate for you, but don’t expect it to improve your heart recovery.

Want to Apply This Research?

  • Track your current vitamin D supplementation dose (if any) and any heart-related symptoms or complications weekly. Log whether you’re following your cardiologist’s recommended medications and cardiac rehabilitation program, as these are proven to help after a heart attack.
  • If you’re currently taking high-dose vitamin D supplements and have had a heart attack, schedule an appointment with your cardiologist to discuss whether you should stop or reduce your dose. Use the app to set a reminder for this appointment and to track your conversation with your doctor.
  • Monitor your adherence to proven heart attack recovery treatments (medications, rehabilitation, lifestyle changes) rather than focusing on vitamin D supplementation. Track any new symptoms or concerns and report them to your cardiologist. Use the app to maintain a log of your heart health metrics that your doctor recommends monitoring.

This article summarizes research from the Target-D trial and should not replace medical advice from your healthcare provider. If you have had a heart attack or have heart disease, consult with your cardiologist before starting, stopping, or changing any supplements, including vitamin D. The findings of this study apply specifically to heart attack patients and may not apply to other populations. Always follow your doctor’s recommendations for cardiac care and recovery.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: More is not always better: vitamin D supplementation post-myocardial infarction in the Target-D trial.European heart journal (2026). PubMed 42702499 | DOI